» Articles » PMID: 3439801

Subinhibitory Concentrations of Tetracycline Alter Fibrinogen Binding by Bacteroides Intermedius

Overview
Specialty Pharmacology
Date 1987 Dec 1
PMID 3439801
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies from our laboratory have shown that a strain of Bacteroides intermedius, VPI 8944, an organism isolated originally from a patient with acute necrotizing ulcerative gingivitis, binds human fibrinogen rapidly, reversibly, specifically, saturably, and with high affinity (M.S. Lantz, L.M. Switalski, K.S. Kornman, and M. Höök, J. Bacteriol. 163:623-628, 1985). We examined the effect of growth in subinhibitory levels (sub-MICs) of tetracycline on fibrinogen binding by these bacteria and found concentration-dependent inhibition of fibrinogen binding by bacteria grown in the presence of tetracycline over the range of tetracycline concentrations from 1/64 to 1/8 the MIC. Analysis of the binding data suggests that bacteria grown in the presence of sub-MICs of tetracycline bind fewer fibrinogen molecules per cell than do bacteria grown in the absence of the drug. If fibrinogen-mediated adherence is important in the establishment B. intermedius in periodontal lesions and lesions of acute necrotizing ulcerative gingivitis, then tetracycline may be effective in disrupting establishment of these organisms at concentrations well below those required to achieve a bacteriostatic effect.

Citing Articles

What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?.

Dorey L, Hobson S, Lees P J Vet Pharmacol Ther. 2017; 40(5):517-529.

PMID: 28101885 PMC: 5600113. DOI: 10.1111/jvp.12386.


Systemic anti-microbial agents used in periodontal therapy.

Patil V, Mali R, Mali A J Indian Soc Periodontol. 2013; 17(2):162-8.

PMID: 23869120 PMC: 3713745. DOI: 10.4103/0972-124X.113063.


Systemic antibiotic therapy in periodontics.

Kapoor A, Malhotra R, Grover V, Grover D Dent Res J (Isfahan). 2013; 9(5):505-15.

PMID: 23559912 PMC: 3612184. DOI: 10.4103/1735-3327.104866.


Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Zhanel G, Hoban D, Harding G Can J Infect Dis. 2012; 3(4):193-201.

PMID: 22514370 PMC: 3328040. DOI: 10.1155/1992/793607.

References
1.
Syed S, Loesche W . Bacteriology of human experimental gingivitis: effect of plaque age. Infect Immun. 1978; 21(3):821-9. PMC: 422071. DOI: 10.1128/iai.21.3.821-829.1978. View

2.
Lantz M, Rowland R, Switalski L, Hook M . Interactions of Bacteroides gingivalis with fibrinogen. Infect Immun. 1986; 54(3):654-8. PMC: 260219. DOI: 10.1128/iai.54.3.654-658.1986. View

3.
Ciancio S, Mather M, McMullen J . An evaluation of minocycline in patients with periodontal disease. J Periodontol. 1980; 51(9):530-4. DOI: 10.1902/jop.1980.51.9.530. View

4.
Genco R . Antibiotics in the treatment of human periodontal diseases. J Periodontol. 1981; 52(9):545-58. DOI: 10.1902/jop.1981.52.9.545. View

5.
Gordon J, Walker C, Murphy J, Goodson J, Socransky S . Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses. J Periodontol. 1981; 52(10):609-12. DOI: 10.1902/jop.1981.52.10.609. View